文献速递骨肌技术与安全CT

量化机会性CT骨密度筛查的机会与经济价值:一项Medicare数据库分析

Quantifying the Opportunity and Economic Value of Bone Density Screening Using Opportunistic CT: A Medicare Database Analysis.
PubMed 文献 · J Am Coll Radiol · 2025-01-01

基于Medicare 2015-2022年5%研究可识别文件,分析2,897,040名受益人,评估机会性CT骨密度筛查对筛查率与成本避免的影响。仅用非增强CT可使骨质疏松筛查率提高76%,用所有CT提高113%;

要点

  • 22.7%受益人未做DEXA但至少一次CT包含L1椎体,其中非增强占67.8%、增强占32.2%。
  • 非增强CT组1年内髋部脆性骨折0.6%、脊柱5.3%;增强CT组分别为0.3%、2.5%。
  • 仅非增强CT可使骨质疏松筛查率提高76%,使用所有CT可提高113%。

核心结论

  • 实施机会性CT骨密度筛查可能对患者诊疗和经济产生实质性影响。

研究设计与样本

  • 基于Medicare 5%研究可识别文件(2015-2022)的数据库分析,共纳入2,897,040名受益人,通过当前操作术语代码识别DEXA及含相关体部区域的增强和/或非增强CT。

诊断标准与关键数值

  • 584,391名受益人(20.2%)接受DEXA;658,703名(22.7%)未接受DEXA但至少一次CT包含L1椎体,其中446,706名(67.8%)为非增强、211,997名(32.2%)为增强。
  • 非增强CT组1年内髋部脆性骨折2,766例(0.6%)、脊柱脆性骨折23,889例(5.3%);增强CT组分别为613例(0.3%)和5,222例(2.5%)。
  • 仅使用非增强CT可使骨质疏松筛查率提高76%,使用所有CT可提高113%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of this study was to determine the potential impact of opportunistic CT bone density screening in terms of increasing screening rates and cost avoidance.

METHODS: The analytic dataset was extracted from the Medicare 5% Research Identifiable Files (2015-2022). All dual-energy x-ray absorptiometry (DEXA) procedures and contrast and/or noncontrast CT procedures of pertinent body regions were identified using Current Procedural Terminology codes. Outcomes of interest included osteoporosis screening imaging and fragility fractures of the hip or spine. Potential annual cost avoidance was calculated.

RESULTS: In total, 2,897,040 beneficiaries were identified for analysis, of whom 584,391 beneficiaries (20.2%) underwent DEXA and 658,703 beneficiaries (22.7%) did not undergo DEXA but did undergo at least one CT examination that included the L1 vertebral body, 446,706 (67.8%) without and 211,997 (32.2%) with contrast. In the noncontrast and contrast CT groups, there were 2,766 (0.6%) and 613 (0.3%) hip and 23,889 (5.3%) and 5,222 (2.5%) spine fragility fractures within 1 year of CT. The osteoporosis screening rate would increase by 76% using only noncontrast CT studies and by 113% using all CT studies. If only noncontrast CT was used to identify osteoporosis and treatment was successfully implemented in 100% of eligible beneficiaries, this study population would see a medical cost avoidance in excess of $17 million. If any CT was used, potential annual cost avoidance for this study's population would be nearly $100 million and $2.5 billion for all 2023 Medicare fee-for-service beneficiaries.

CONCLUSIONS: Implementing opportunistic CT bone density screening could potentially have a substantial patient care and economic impact.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Gyftopoulos S, Pelzl CE, Chang CY, et al. Quantifying the Opportunity and Economic Value of Bone Density Screening Using Opportunistic CT: A Medicare Database Analysis. J Am Coll Radiol. 2025. PMID: 40044314. doi:10.1016/j.jacr.2024.10.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。